Previous 10 | Next 10 |
BRIDGEWATER, N.J., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today a poster presentati...
BRIDGEWATER, N.J., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today a poster presentati...
BRIDGEWATER, N.J., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today it will be hosting ...
Immuron (NASDAQ: IMRN ) +34% on new research agreement with the Naval Medical Research Center. More news on: Immuron Limited, The Stars Group Inc., Axsome Therapeutics, Inc., Stocks on the move, Read more ...
Valeritas Holdings (NASDAQ: VLRX ) restructures a substantial portion of its outstanding long-term debt, reducing the total debt balance by an aggregate of $25M. More news on: Valeritas Holdings, Inc., Healthcare stocks news, Stocks on the move, Read more ...
- Debt Exchange Expected to Save Approximately $8 Million in Cash Interest Expense - - Provides Corporate Updates Including Expectation That Third Quarter U.S. Revenue Will Grow 30% Over Prior Year - BRIDGEWATER, N.J., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. ...
BRIDGEWATER, N.J., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today that Dr. Jessica B...
BRIDGEWATER, N.J., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its p...
BRIDGEWATER, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today data from its prec...
BRIDGEWATER, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today a poster presentat...
News, Short Squeeze, Breakout and More Instantly...
BRIDGEWATER, N.J. , Feb. 9, 2020 /PRNewswire/ -- Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device , today announced an agreement to sell substantially all of the business to Z...
BRIDGEWATER, N.J., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , today announced revised revenue guida...
BRIDGEWATER, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its pr...